Sources | Names Used |
---|---|
CCLE, GRAY | PF-2341066 |
GDSC1000, FIMM | Crizotinib |
gCSI, CTRPv2 | crizotinib |
PharmacoGx | Crizotinib |
Database | Identifier |
---|---|
Smiles: | CC(C1=C(C=C(C=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N |
Inchikey: | SCJHEFQWKWHQTO-GFCCVEGCSA-N |
Pubchem: | 54613769 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ACAT2 | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
mRNA | ACOT11 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | ACOT12 | CCLE | pan-cancer | AAC | 0.16 | 0.0002 |
mRNA | ACOX1 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
mRNA | ACOX2 | gCSI | pan-cancer | AAC | 0.18 | 0.003 |
mRNA | ACPP | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
mRNA | ACRC | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0003 |
mRNA | ACSM1 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
mRNA | ACSM3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | ACTN4 | GDSC1000 | pan-cancer | AAC | 0.21 | 0.001 |